Related Experiment Videos
Cell-mediated cytotoxicity against HeLa cells in patients with invasive or preinvasive cervical cancer
Journal of the National Cancer Institute
|October 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rb-loss is associated with high malignancy in chondrosarcoma.
Oncology reports·2005
A fluorometric method for the differentiation of algal populations in vivo and in situ.
Photosynthesis research·2005
"Best friends" sharing the HMGA1 gene: comparison of the human and canine HMGA1 to orthologous other species.
The Journal of heredity·2005
Intermittent administration of betalactam-antibiotics for treatment of severe infection in hemodialysis patients.
European journal of medical research·2005
Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage.
International journal of clinical pharmacology and therapeutics·2004
Immediate postoperative angiography after aneurysm clipping--implications for quality control and guidance of further management.
Zentralblatt fur Neurochirurgie·2004
Efficacy and toxicity of antibody-drug conjugates in older adults with breast cancer: A systematic review and meta-analysis.
Journal of the National Cancer Institute·2026
Foundation models for cancer: advancing diagnosis, prognosis, and treatment response-an NCI workshop report.
Journal of the National Cancer Institute·2026
Effects of private health insurance coverage gains on colorectal cancer outcomes: a modeling study.
Journal of the National Cancer Institute·2026
Novel framework for the validation of intermediate clinical endpoints in oncology real-world data.
Journal of the National Cancer Institute·2026
Time trends of human papillomavirus-attributable head and neck cancers: the BROADEN study.
Journal of the National Cancer Institute·2026
Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
Journal of the National Cancer Institute·2026